E. Ehrnrooth

2.6k citations
47 papers · 2k · 1 hit paper · h-index 19

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research

Papers in

    • Head and Neck Cancer Studies 9
    • Cancer Immunotherapy and Biomarkers 7
    • Colorectal Cancer Treatments and Studies 4
    • Cancer Treatment and Pharmacology 2

E. Ehrnrooth

47 papers receiving 2k citations

E. Ehrnrooth's Hit Papers

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial 2015 · 333 citations
3330+3+7Years since publication100200300

Peers

E. Ehrnrooth
Comparison fields: 5 of 97
  • Otorhinolaryngology 489
  • Oncology 528
  • Immunology 277
  • General Health Professions 240
  • Pulmonary and Respiratory Medicine 217
Replace Samario Chaitchik with:
Samario Chaitchik Israel
Liye Zhou China
Michael Hier Canada
Gang Cheng China
Victoria Bray Australia
Stephen P. Richman United States
Geert H. Blijham Netherlands
Miriam N. Lango United States
T.J. Priestman United Kingdom
Stefan Nicholas Symeonides United Kingdom
E. Ehrnrooth relative to Samario Chaitchik Israel Samario Chaitchik's profile →
Citations per field
00.5×10×20×30×41×
Samario Chaitchik · 1×
Citations per year

Countries citing papers authored by E. Ehrnrooth

Since Specialization
Citations

This map shows the geographic impact of E. Ehrnrooth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Ehrnrooth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Ehrnrooth more than expected).

Fields of papers citing papers by E. Ehrnrooth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Ehrnrooth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Ehrnrooth. The network helps show where E. Ehrnrooth may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Ehrnrooth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Ehrnrooth Line = papers co-authored together E. Ehrnrooth links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003483
2
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
Hit paper breakdown →
2015333
3 2021167
4 2020164
5 2014159
6 199890
7 201272
8 201767
9 201848
10 199138
11 201938
12 202237
13 202335
14 201634
15 201332
16 201726
17 200925
18 201725
19 201925
20 199217

About E. Ehrnrooth

E. Ehrnrooth is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Rheumatology, having authored 47 papers that have together received 2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Head and Neck Cancer Studies (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Nitric Oxide and Endothelin Effects (2 papers), Cancer Treatment and Pharmacology (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Otorhinolaryngology (489 citations), Oncology (528 citations), Immunology (277 citations), General Health Professions (240 citations) and Pulmonary and Respiratory Medicine (217 citations). E. Ehrnrooth has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Hans von der Maase, Charlotte Gjørup Pedersen, Philip Blach Rossen, Robert Hugh Zachariae, Anders Bonde Jensen, Ezra E.W. Cohen, Mai-Britt Zocca, Paul M. Clément, Jérôme Fayette and Didier Cupissol. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, European Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact